| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |